These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26935281)

  • 41. Autoimmunity and transplantation: a meeting at the crossroads in Berlin.
    Sawitzki B; Reinke P; Volk HD; Wood K; Turka LA
    Nat Immunol; 2008 May; 9(5):447-9. PubMed ID: 18425094
    [No Abstract]   [Full Text] [Related]  

  • 42. Inducing tissue specific tolerance in autoimmune disease with tolerogenic dendritic cells.
    Suwandi JS; Toes RE; Nikolic T; Roep BO
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S97-103. PubMed ID: 26458178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.
    Tang Q; Henriksen KJ; Bi M; Finger EB; Szot G; Ye J; Masteller EL; McDevitt H; Bonyhadi M; Bluestone JA
    J Exp Med; 2004 Jun; 199(11):1455-65. PubMed ID: 15184499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part II.
    Ballotti S; Chiarelli F; de Martino M
    Horm Res; 2006; 66(3):142-52. PubMed ID: 16807509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinant spreading and the dynamics of the autoimmune T-cell repertoire.
    Lehmann PV; Sercarz EE; Forsthuber T; Dayan CM; Gammon G
    Immunol Today; 1993 May; 14(5):203-8. PubMed ID: 7686009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?
    Askenasy N
    Immunol Res; 2016 Feb; 64(1):36-43. PubMed ID: 26482052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
    Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
    Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection.
    Picca CC; Larkin J; Boesteanu A; Lerman MA; Rankin AL; Caton AJ
    Immunol Rev; 2006 Aug; 212():74-85. PubMed ID: 16903907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulatory T Cells: A Crisis Averted.
    Malhotra D; Jenkins MK
    Immunity; 2016 May; 44(5):1079-81. PubMed ID: 27192571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoimmunity. How to know thy self.
    Hafler DA; Flavell R
    Curr Opin Immunol; 1996 Dec; 8(6):805-7. PubMed ID: 8994859
    [No Abstract]   [Full Text] [Related]  

  • 51. An autoimmune "attack" on melanocytes triggers psoriasis and cellular hyperplasia.
    Krueger JG
    J Exp Med; 2015 Dec; 212(13):2186. PubMed ID: 26666753
    [No Abstract]   [Full Text] [Related]  

  • 52. How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation.
    Ioannidis JPA; Kim BYS; Trounson A
    Nat Biomed Eng; 2018 Nov; 2(11):797-809. PubMed ID: 30931172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanomedicine applications in women's health: state of the art.
    Lloyd-Parry O; Downing C; Aleisaei E; Jones C; Coward K
    Int J Nanomedicine; 2018; 13():1963-1983. PubMed ID: 29636611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell Membrane Bioconjugation and Membrane-Derived Nanomaterials for Immunotherapy.
    Li PY; Fan Z; Cheng H
    Bioconjug Chem; 2018 Mar; 29(3):624-634. PubMed ID: 29323870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoimmunity: Antigen-specific immunotherapy.
    Wraith D
    Nature; 2016 Feb; 530(7591):422-3. PubMed ID: 26886797
    [No Abstract]   [Full Text] [Related]  

  • 56. Autoimmunity: Nanoparticles engineered for antigen-specific immunotherapy.
    Flemming A
    Nat Rev Drug Discov; 2016 Apr; 15(4):233. PubMed ID: 27032832
    [No Abstract]   [Full Text] [Related]  

  • 57. Autoimmunity: Nanoparticles engineered for antigen-specific immunotherapy.
    Flemming A
    Nat Rev Immunol; 2016 Apr; 16(4):204-5. PubMed ID: 27026072
    [No Abstract]   [Full Text] [Related]  

  • 58. Antigen-induced regulatory T cells in autoimmunity.
    von Herrath MG; Harrison LC
    Nat Rev Immunol; 2003 Mar; 3(3):223-32. PubMed ID: 12658270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoimmunity: Nanomedicine, meet autoimmune disease.
    Barranco C
    Nat Rev Rheumatol; 2016 Apr; 12(4):193. PubMed ID: 26935281
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.